Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34+ hematopoietic cells

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1107-1112

  Papadimitriou, Christos A ^a   Roots, Angela ^a   Koenigsmann, Michael ^a   Oelmann, Elisabeth ^a   Topp, Max S ^a   Oberberg, Dorothea ^a   Reufi, Birgit ^a   Thiel, Eckhard ^a   Berdel, Wolfgang E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cryopreserved bone marrow; immunomagnetic separation; leukapheresis products; positive stem cell selection

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL ISOLATION; CONTROLLED STUDY; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAGNETISM; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0029828823     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1107     Document Type: Article

References (30)

1. Andrews RG, Singer JW and Bernstein ID: Monoclonal antibody 12.8 recognizes a 115-Kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their procursors. Blood 67: 842-845, 1986.
2. Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart RK and Civin CI: Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14: 878-886, 1986.
3. Brandt J, Baird N, Lu L, Srour E and Hoffman R: Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 82: 1017-1027, 1988.
4. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF and Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133: 157-165, 1984.
5. Sutherland DR, Stewart AK and Keating A: CD34 antigen: Molecular features and potential clinical applications. Stem Cells 11 (Suppl 3): 50-57, 1993.
6. Berenson RJ, Andews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD and Bernstein ID: Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J Clin Invest 81: 951-955, 1988.
7. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77: 1717-1722, 1991.
8. Watt SM, Karhi K, Gatter K, Furley AJW, Katz FE, Healy LE, Altass LJ, Bradley NJ, Sutherland DR, Levinsky R and Greaves MF: Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-I) associated with human hematopoietic progenitor cells. Leukemia 1: 417-426, 1987.
9. Bernstein ID: Hematopoietic stem cell transplants. In: Recent Advances in Leukemia and Lymphoma. RP Gale, DW Golde (eds), UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 61, Wiley-Liss, New York, p527, 1987.
10. Berenson RJ, Bensinger WI and Kalamasz DF: Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Methods 91: 11-19, 1986.
11. Berenson RJ, Bensinger WI, Hill R, Andrews RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Buckner CD, Bernstein ID and Thomas ED: Stem cell selection - clinical experience. In: Bone Marrow Purging and Processing: Progress in Clinical and Biological Research. S Gross, AP Gee, DA Worthington-White (eds), Vol. 333, Wiley-Liss, New York, p403, 1990.
12. Gee AP, Moss T, Mansour V, Kulcinski D, Law P, Ishizawa L and Hardwick A: Large-scale immunomagnetic separation system for the removal of tumor cells from bone marrow. In: Advances in Bone Marrow Purging and Processing. DA Worthington-White, AP Gee, S Gross (eds), Wiley-Liss, New York, pp181-187, 1992.
13. Strauss LC, Trischmann TM, Rowley SD, Wiley JM and Civin CI: Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol/Oncol 2: 217-221, 1991.
14. Lebkowski JS, Schain LR, Okrongly D, Levinsky R, Harvey MJ and Okarma TB: Rapid isolation of human CD34 hematopoietic stem cells-purging of human tumor cells. Transplantation 53: 1011-1019, 1992.
15. + cord blood. Pediatr Res 32: 277-281, 1992.
16. + cells from human bone marrow, cord blood, and mobilized peripheral blood. J Hematother 2: 333-338, 1993.
17. + cells from cord blood. J Hematother 2: 247-250, 1993.
18. Yeager AM, Wiley JM, Jones R, Rowley SD, Zuehlsdorf M, Colvin OM and Santos GW: Pharmacologic treatment of bone marrow to eliminate clonogenic tumor cells: Laboratory and clinical studies. Bone Marrow Transplant 2 (Suppl 2): 34, 1987.
19. Freedman AS and Nadler LM: Developments in purging in autotransplantation. Hematol/Oncol Clin North Amer 7: 687, 1993.
20. Moss TJ and Ross AA: The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematother 1: 225-232, 1992.
21. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A and Borkett K: Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow-transplantation in lymphoma patients. Lancet 347: 353-357, 1996.
22. Hardwick RA, Kulcinski D, Mansour V, Ishizawa L, Law P and Gee AP: Design of large-scale separations systems for positive and negative immunomagnetic selection of cells using superparamagnetic microspheres. J Hematother 1: 379-386, 1992.
23. + hematopoietic precursors: Clinical rationale. Transplantation Proc 24: 3032-3034, 1992.
24. Bodine DM, Orlic D, Birkett NC, Seidel NE and Zsebo KM: Stem cell factor increases CFU-S number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor. Blood 79: 913-919, 1992.
25. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T and Hoffman R: Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81: 661-669, 1993.
26. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R and Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 333: 283-287, 1995.
27. Koenigsmann MP, Notter M, Knauf WU, Papadimitriou CA, Oberberg D, Reufi B, Mücke C, Thiel E and Berdel WE: Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy. Bone Marrow Transplant (In press).
28. Berdel WE, Okamoto S, Reichert A, Olson AC, Winton EF, Rastetter J and Vogler W: Studies on the role of ether lipids as purging agents in autologous bone marrow transplantation. In: The Pharmacological Effects of Lipids III. JJ Kabara (ed), Champaign IL: The American Oil Chemists' Society, AOCS-Press, pp338-360, 1989.
29. Berdel WE: Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer 64: 208-211, 1991.
30. Vogler WR, Berdel WE, Olson AC, Winton EF, Heffner LT and Gordon DS: Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood 80: 1423-1429, 1992.